World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
84
Citations
32863
World Ranking
1342
National Ranking
691

Overview

Eli O. Meltzer is affiliated with the University of California, Berkeley in the United States. Their research primarily focuses on medicine, with significant contributions in immunology and allergy, physiology, pulmonary and respiratory medicine, otorhinolaryngology, and surgery.

The main topics covered in Meltzer's work include:

  • Allergic Rhinitis and Sensitization
  • Asthma and Respiratory Diseases
  • Respiratory and Cough-Related Research
  • Sinusitis and Nasal Conditions
  • Nasal Surgery and Airway Studies
  • Olfactory and Sensory Function Studies
  • Pediatric Health and Respiratory Diseases

Meltzer has published research in several journals, with frequent publications in:

  • Journal of Allergy and Clinical Immunology
  • Allergy and Asthma Proceedings
  • Allergy Asthma and Clinical Immunology
  • Annals of Allergy Asthma & Immunology
  • Current Medical Research and Opinion

Some of Meltzer's recent papers include:

  • "Prevalence and Burden of Chronic Cough in the United States" (2021), published in The Journal of Allergy and Clinical Immunology In Practice
  • "Fexofenadine: review of safety, efficacy and unmet needs in children with allergic rhinitis" (2021), published in Allergy Asthma and Clinical Immunology

Other notable recent publications, where Meltzer may be involved as a co-author or within the relevant research context, are:

  • "Rhinitis 2020: A practice parameter update" (2020), Journal of Allergy and Clinical Immunology
  • "ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy" (2021), Clinical and Translational Allergy
  • "Shifts in allergy practice in a COVID-19 world: Implications of pre-COVID-19 national health care provider and patient surveys of treatments for nasal allergies" (2021), Allergy and Asthma Proceedings

Meltzer has collaborated frequently with various co-authors, including:

  • Dana Wallace
  • Jonathan A. Bernstein
  • Robert S. Zeiger
  • Peter V. Dicpinigaitis
  • Nelson Augusto Rosário Filho

Best Publications

  • Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)

    J. Bousquet;N. Khaltaev;A. A. Cruz;J. Denburg

  • Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision

    Jan L. Brożek;Jean Bousquet;Ioana Agache;Arnav Agarwal

  • Rhinosinusitis: Establishing definitions for clinical research and patient care

    Eli O. Meltzer;Daniel L. Hamilos;James A. Hadley;Donald C. Lanza

  • Rhinosinusitis: developing guidance for clinical trials.

    Eli O. Meltzer;Daniel L. Hamilos;James A. Hadley;Donald C. Lanza

  • Burden of allergic rhinitis: Results from the Pediatric Allergies in America survey

    Eli O. Meltzer;Michael S. Blaiss;M. Jennifer Derebery;Todd A. Mahr

  • Quality of life in adults and children with allergic rhinitis.

    Eli O. Meltzer

  • A Randomized, Controlled, Phase 2 Study of AMG 317, an IL-4Rα Antagonist, in Patients with Asthma

    Jonathan Corren;William Busse;Eli O. Meltzer;Lyndon Mansfield

  • Detection of Growth Suppression in Children During Treatment With Intranasal Beclomethasone Dipropionate

    David P. Skoner;Gary S. Rachelefsky;Eli O. Meltzer;Paul Chervinsky

  • Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: A randomized, placebo-controlled clinical trial

    Eli O. Meltzer;Kerstin Malmstrom;Susan Lu;Bruce M. Prenner

  • Rhinitis 2020: A practice parameter update

    Unknown

  • Prevalence of allergic rhinitis in the United States

    Robert A. Nathan;Eli O. Meltzer;John C. Seiner;William Storms

  • A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis

    Warner Carr;Jonathan Bernstein;Phil Lieberman;Eli Meltzer

  • The economic impact of allergic rhinitis and current guidelines for treatment.

    Eli O. Meltzer;Don A. Bukstein

  • Burden of allergic rhinitis: allergies in America, Latin America, and Asia-Pacific adult surveys.

    Eli O Meltzer;Michael S Blaiss;Robert M Naclerio;Stuart W Stoloff

  • Treating acute rhinosinusitis: Comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo

    Eli O. Meltzer;Claus Bachert;Heribert Staudinger

  • Rhinosinusitis Diagnosis and Management for the Clinician: A Synopsis of Recent Consensus Guidelines

    Eli O. Meltzer;Daniel L. Hamilos

  • MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation

    J. Bousquet;H. J. Schunemann;J. Fonseca;B. Samolinski

  • Allergic Rhinitis

    Unknown

  • ICON: chronic rhinosinusitis

    Claus Bachert;Ruby Pawankar;Luo Zhang;Chaweewan Bunnag

  • Cetirizine in patients with seasonal rhinitis and concomitant asthma: prospective, randomized, placebo-controlled trial☆☆☆★★★

    J A Grant;C F Nicodemus;S R Findlay;M M Glovsky

  • Efficacy and safety of loratadine plus pseudoephedrine in patients with seasonal allergic rhinitis and mild asthma

    Jonathan Corren;Alan G. Harris;Donald Aaronson;Wilfred Beaucher

  • Sleep, quality of life, and productivity impact of nasal symptoms in the United States: findings from the Burden of Rhinitis in America survey.

    Eli O. Meltzer;Robert Nathan;Jennifer Derebery;Paul E. Stang

Frequent Co-Authors

Robert A. Nathan
Robert A. Nathan University of Colorado Colorado Springs
Claus Bachert
Claus Bachert Karolinska Institute
David Price
David Price University of Aberdeen
Robert M. Naclerio
Robert M. Naclerio University of Chicago
Jean Bousquet
Jean Bousquet University of Montpellier
Thomas B. Casale
Thomas B. Casale University of South Florida
Ruby Pawankar
Ruby Pawankar Nippon Medical School
Phil Lieberman
Phil Lieberman University of Tennessee at Knoxville
William W. Busse
William W. Busse University of Wisconsin–Madison

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, pursuing related nursing degrees can open diverse career opportunities. Many professionals start with an online ADN programs for non nurses, designed to help career changers enter the nursing field efficiently.

Once in nursing, advancing through an accelerated NP program can speed up the path to becoming a nurse practitioner, allowing for specialization in areas such as immunology-related acute care.

Transitioning from general practice to specialized roles, including becoming an acute care nurse practitioner, requires certification. Guidance on this process is well outlined in resources about acute care nurse practitioner certification, which is critical for those aiming to work with immunocompromised or critically ill patients.

Salary expectations vary by location and certification. Understanding the dnp salary across different states can help professionals plan their careers strategically, ensuring their education investment aligns with financial goals.

Best Scientists Citing Eli O. Meltzer

Trending Scientists

Recently Published Articles